ID   HyCyte A-549 hRB1CC1_p.R474H_c.1421G>A_c.1422C>T cell line
AC   CVCL_F4JU
SY   hRB1CC1_p.R474H_c.1421G>A_c.1422C>T cell line
DR   Hysigen; CGMU-M2206
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGMU-M2206).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15574; RB1CC1; Simple_edited; p.R474H (NM_001083617.1:c.1421_1422GC>AT); Zygosity=Homozygous (Hysigen=CGMU-M2206).
CC   Sequence variation: Mutation; HGNC; HGNC:15574; RB1CC1; Simple_edited; p.L475L (NM_001083617.1:c.1425C>G); Zygosity=Homozygous; Note=Synonymous mutation (Hysigen=CGMU-M2206).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//